GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC.
1] Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT, USA [2] Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, CT, USA [3] Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Rajiv
R
Radhakrishnan
1] Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT, USA [2] Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Patrick D
PD
Skosnik
1] Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT, USA [2] Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, CT, USA [3] Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Jose
J
Cortes-Briones
1] Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT, USA [2] Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, CT, USA [3] Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
R Andrew
RA
Sewell
1] Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT, USA [2] Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, CT, USA [3] Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Michelle
M
Carbuto
1] Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT, USA [2] Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, CT, USA [3] Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Ashley
A
Schnakenberg
1] Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT, USA [2] Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
John
J
Cahill
1] Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT, USA [2] Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Fred
F
Bois
1] Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT, USA [2] Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Handan
H
Gunduz-Bruce
1] Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, CT, USA [2] Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Brian
B
Pittman
1] Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT, USA [2] Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, CT, USA [3] Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Mohini
M
Ranganathan
1] Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT, USA [2] Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, CT, USA [3] Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Deepak Cyril
DC
D'Souza
D000293:Adolescent; D000328:Adult; D001931:Brain Mapping; D004213:Dissociative Disorders / Q000139:chemically induced*; D004311:Double-Blind Method; D013759:Dronabinol / Q000097:blood / Q000494:pharmacology*; D004569:Electroencephalography; D018913:Event-Related Potentials, P300 / Q000187:drug effects*; D005442:Flumazenil / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D010147:Pain Measurement; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D011619:Psychotropic Drugs / Q000494:pharmacology*; D055815:Young Adult; D005680:gamma-Aminobutyric Acid / Q000172:deficiency*
D011619:Psychotropic Drugs; D005442:Flumazenil; D005680:gamma-Aminobutyric Acid; C063038:iomazenil; D013759:Dronabinol